Andrew Fesler

876 citations
21 papers · 644 indexed · h-index 14
Topics
MicroRNA in disease regulation (19 papers)Cancer-related molecular mechanisms research (10 papers)RNA modifications and cancer (7 papers)
Journals
SHILAP Revista de lepidopterologíaCancer ResearchMolecular Therapy

In The Last Decade

Andrew Fesler

21 papers receiving 637 citations

Peers

Andrew Fesler
Comparison fields: 5 of 66
  • Cancer Research 505
  • Molecular Biology 473
  • Epidemiology 104
  • Oncology 92
  • Surgery 35
Replace Y-Y Wu with:
Y-Y Wu China
Tiziana La Bella France
Jovanna González Spain
Jinhua Han China
Xiaoling Li China
Dean A. Fennell United Kingdom
Wanyi Lin China
Blanca Majem Spain
Qiongzi Qiu China
Ali Özeş United States
Andrew Fesler relative to Y-Y Wu China Y-Y Wu's profile →
Citations per field
00.5×1.5×1.9×
Y-Y Wu · 1×
Citations per year

Countries citing papers authored by Andrew Fesler

Since Specialization
Citations

This map shows the geographic impact of Andrew Fesler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Fesler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Fesler more than expected).

Fields of papers citing papers by Andrew Fesler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Fesler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Fesler. The network helps show where Andrew Fesler may publish in the future.

Co-authorship network of co-authors of Andrew Fesler

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Fesler. A scholar is included among the top collaborators of Andrew Fesler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Fesler. Andrew Fesler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 5
3 7
4 8
5 17
6 36
7 41
8 15
9 1
10 43
11 23
12 14
13 36
14 47
15 9
16
miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer
4
17 28
18 32
19 72
20 94

About Andrew Fesler

Andrew Fesler is a scholar working on Cancer Research, Molecular Biology and Epidemiology, having authored 21 papers that have together received 644 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (505 citations), Molecular Biology (473 citations) and Oncology (92 citations). Andrew Fesler has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Jingfang Ju, Haiyan Zhai, Song Wu, Yufeng Ba, Hua Liu, Øystein Fodstad, Kjersti Flatmark, Kristina Schee, Shixiang Guo and Huaizhi Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026